These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11166353)

  • 1. The SENIEUR protocol after 16 years: the next step is to study the interaction of ageing and disease.
    Ligthart GH
    Mech Ageing Dev; 2001 Feb; 122(2):136-40. PubMed ID: 11166353
    [No Abstract]   [Full Text] [Related]  

  • 2. The SENIEUR protocol after 16 years.
    Pawelec G; Ferguson FG; Wikby A
    Mech Ageing Dev; 2001 Feb; 122(2):132-4. PubMed ID: 11166351
    [No Abstract]   [Full Text] [Related]  

  • 3. The SENIEUR Protocol after 16 years: a need for a paradigm shift?
    Castle SC; Uyemura K; Makinodan T
    Mech Ageing Dev; 2001 Feb; 122(2):127-30. PubMed ID: 11166349
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of the SENIEUR protocol: distinction between "ideal aging" and clinical reality.
    Ershler WB
    Mech Ageing Dev; 2001 Feb; 122(2):134-6. PubMed ID: 11166352
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum immunoglobulin class and IgG subclass levels and the occurrence of homogeneous immunoglobulins during the course of ageing in humans.
    De Greef GE; Van Tol MJ; Van Den Berg JW; Van Staalduinen GJ; Janssen CJ; Radl J; Hijmans W
    Mech Ageing Dev; 1992; 66(1):29-44. PubMed ID: 1340514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New paradigms for research on aging and late-life illness.
    Miller RA
    Mech Ageing Dev; 2001 Feb; 122(2):130-2. PubMed ID: 11166350
    [No Abstract]   [Full Text] [Related]  

  • 7. Age-related changes of the antigen-specific antibody formation in vitro and PHA-induced T-cell proliferation in individuals who met the health criteria of the Senieur protocol.
    De Greef GE; Van Staalduinen GJ; Van Doorninck H; Van Tol MJ; Hijmans W
    Mech Ageing Dev; 1992; 66(1):1-14. PubMed ID: 1340510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol.
    Ligthart GJ; Corberand JX; Geertzen HG; Meinders AE; Knook DL; Hijmans W
    Mech Ageing Dev; 1990 Jul; 55(1):89-105. PubMed ID: 2205767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of reference intervals from a SENIEUR protocol compatible aged population for immunogerontological studies.
    Stulnig T; Mair A; Jarosch E; Schober M; Schönitzer D; Wick G; Huber LA
    Mech Ageing Dev; 1993 May; 68(1-3):105-15. PubMed ID: 8350651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reference values in immunodiagnosis: the approach using the Senieur protocol].
    Dekaric D; Matijević Lj; Sabioncello A; Rabatić S; Mazuran R; Svoboda-Beusan I; Ajduković G; Skrt E; Henc-Petrinović Lj; Kis S
    Glas Srp Akad Nauka Med; 1991; (41):11-4. PubMed ID: 1916437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission criteria for immunogerontological studies in man: the SENIEUR protocol.
    Ligthart GJ; Corberand JX; Fournier C; Galanaud P; Hijmans W; Kennes B; Müller-Hermelink HK; Steinmann GG
    Mech Ageing Dev; 1984 Nov; 28(1):47-55. PubMed ID: 6513613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ageing on antibody formation in vivo after immunisation with the primary T-cell dependent antigen Helix pomatia haemocyanin.
    De Greef GE; Van Tol MJ; Kallenberg CG; Van Staalduinen GJ; Remarque EJ; Tjandra YI; Hijmans W
    Mech Ageing Dev; 1992; 66(1):15-28. PubMed ID: 1340513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly.
    Trzonkowski P; Myśliwska J; Pawelec G; Myśliwski A
    Biogerontology; 2009 Feb; 10(1):83-94. PubMed ID: 18563620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ImAginE: Immunology and Ageing in Europe--a thematic network of the EU 5th Framework Program.
    Pawlwec G
    Exp Gerontol; 2000 Oct; 35(8):1107-8. PubMed ID: 11215502
    [No Abstract]   [Full Text] [Related]  

  • 15. Approach to define "normal aging" in man. Immune function, serum lipids, lipoproteins and neopterin levels.
    Reibnegger G; Huber LA; Jürgens G; Schönitzer D; Werner ER; Wachter H; Wick G; Traill KN
    Mech Ageing Dev; 1988 Dec; 46(1-3):67-82. PubMed ID: 3226163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ageing-associated changes in cellular immunity based on the SENIEUR protocol.
    Wu J; Li W; Liu Z; Zhang YY; Peng Y; Feng DG; Li LH; Wang LN; Liu L; Li L; Liu J
    Scand J Immunol; 2012 Jun; 75(6):641-6. PubMed ID: 22443369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological research on ageing: an orientation.
    Miettenen OS
    Int J Epidemiol; 1991; 20 Suppl 1():S2-7. PubMed ID: 9119544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunology of aging: immunoregulatory role of lipoproteins].
    Huber LA
    Wien Klin Wochenschr; 1989 Jun; 101(13):440-6. PubMed ID: 2548349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum glycoprotein hormones and their free alpha-subunit in a healthy elderly population selected according to the SENIEUR protocol. Analyses with ultrasensitive time resolved fluoroimmunoassays.
    Madersbacher S; Stulnig T; Huber LA; Schönitzer D; Dirnhofer S; Wick G; Berger P
    Mech Ageing Dev; 1993 Oct; 71(3):223-33. PubMed ID: 7510812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation marker expression and apoptotic susceptibility of T-cell clones derived from CD34(+), young and SENIEUR donors.
    Valle NS; Bárcia RN; Pawelec G; McLeod JD
    Exp Gerontol; 2004 Apr; 39(4):531-8. PubMed ID: 15050287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.